Larry J. Lesko
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (1996–2021); Center for Drug Evaluation and Research (1996–2011); Massachusetts College of Pharmacy and Health Sciences (1979–1980); University of Massachusetts Chan Medical School (1980); University of Florida (2021)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
L J Lesko's research has focused on understanding pharmacokinetics and therapeutic equivalency, particularly in human subjects. This work utilizes biological and chemical models to investigate how drugs are absorbed, distributed, metabolized, and excreted within the body. Lesko's research also explores the application of pharmacogenomics, investigating how genetic variations influence drug response, with a recent publication in 2021 on population-specific pharmacogenomics in the context of next-generation sequencing. Their work has contributed to a body of knowledge with 25 publications and a citation count of 1,376, supported by an h-index of 13. Lesko collaborates with researchers at the National Center for Toxicological Research, including Baitang Ning, with whom they have co-authored one publication.
Metrics
- h-index: 15
- Publications: 27
- Citations: 1,505
Selected Publications
-
Towards population-specific pharmacogenomics in the era of next-generation sequencing (2021)
Collaboration Network
Top Collaborators
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
- Towards population-specific pharmacogenomics in the era of next-generation sequencing
Similar Researchers
Based on overlapping research topics